ResCu-SR offers a unique combination of highly bioavailable, sustained-release resveratrol and curcumin to support longevity, inflammatory balance, and overall health.

Overall Health: Resveratrol and curcumin have each been the subject of over 4,000 studies and are among the most extensively researched polyphenols. An emerging body of clinical evidence also reveals a progressive convergence of clinical indications for these compounds. Both curcumin and resveratrol are widely recognized approaches to longevity, inflammatory balance, cardioprotection and neurological health. Recent mechanistic studies have characterized functional synergy and cooperativity in antioxidant activity, signal transduction and gene expression.

Innovative sustained-release delivery technology: ResCu-SR was developed using a proprietary MicroActive® delivery technology that renders a soluble, sustained release resveratrol (MicroActive® resveratrol) and a soluble micronized curcumin (MicroActive® curcumin). Superior solubility and absorption performance have been confirmed in dissolution studies and pharmacokinetic trials of both compounds. The MicroActive® technology is a patented delivery system that improves solubility, reduces particle size, improves absorption and provides sustained-release of polyphenols. In a human pilot study, peak plasma resveratrol and area under the curve (AUC) values were 250% greater with MicroActive® Resveratrol compared to an equivalent dose of 98% pure resveratrol. Superior plasma concentrations remained after a 9-hour period.